Therefore, there is a substantial negative connection between IDH2 Lys413 acetylation and breast cancer risk and SIRT3 regulates the progression of breast cancer and the metabolism of breast cancer cells by mediating IDH2 dimerization (Zou et al., 2017). Here, IDH2 is linked to breast carcinoma.